GAAP financial results of $3.01 per diluted share; full-year 2024 non-GAAP adjusted financial results of $3.14 per diluted share Initiating 2025 adjusted ...

Berkshire Hathaway's cash hits a $320B record. Explore insights on stock sales, capital allocation, and the future of the ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

Shares of GE HealthCare (GEHC) jumped 9% Thursday after the company issued its Q4 earnings report and 2025 forecast. Read more here.

GE HealthCare (Nasdaq: GEHC) today reported financial results for the fourth quarter and full year ended December 31, 2024. GE HealthCare President and CEO Peter Arduini ...

The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $1.26 per share. The medical technology company posted revenue of $5.32 billion in the period, falling ...

GE HealthCare posted fourth-quarter revenue growth that came in a touch short of Wall Street's estimates, with results boosted by overall strength in the U.S. market.

Co. shares have surged to a 52-week high, with the stock price hitting $207.89. According to InvestingPro data, the company ...

Full Year 2024 Results Key Financial Results Revenue: US$34.9b (up 5.1% from FY 2023).

China announced retaliatory tariffs on U.S. goods totaling $14 billion in annual sales. Of equal interest, China did not add ...

Bill Holdings tried to break out ahead of earnings. The IBD 50 stock plunged 30% on earnings on Friday, triggering a sell ...